NEJM (The New England Journal of Medicine)

Open in Telegram

All the latest articles published on New England Journal of Medicine before going in to print. And all articles from NEJM Evidence Journal. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot

USA1 391 Medicine759...

📈 Analytical overview of Telegram channel NEJM (The New England Journal of Medicine)

Channel NEJM (The New England Journal of Medicine) (@the_nejm) in the English language segment is an active participant. Currently, the community unites 27 270 subscribers, ranking 759 in the Medicine category and 1 391 in the USA region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 27 270 subscribers.

According to the latest data from 07 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 295 over the last 30 days and by 6 over the last 24 hours, overall reach remains high.

Verification status: Not verified
Engagement rate (ER): The average audience engagement rate is 7.68%. Within the first 24 hours after publication, content typically collects 2.74% reactions from the total number of subscribers.
Post reach: On average, each post receives 2 092 views. Within the first day, a publication typically gains 747 views.
Reactions and interaction: The audience actively supports content: the average number of reactions per post is 2.
Thematic interests: Content is focused on key topics such as medicine, journal, print, cancer, patient.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
“All the latest articles published on New England Journal of Medicine before going in to print. And all articles from NEJM Evidence Journal. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicin...”

Thanks to the high frequency of updates (latest data received on 08 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

27 270

Subscribers

+624 hours

+437 days

+29530 days

2 092

Post views

~ 74724 hours

~ 96748 hours

7.68%

Engagement rate

~ 2

Posts per day

Ads index

beta

Posts Archive

27 263

Adie Tonic Pupil https://www.nejm.org/doi/full/10.1056/NEJMicm2606883?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

27 263

The Long Shadow of Bedlam https://www.nejm.org/doi/full/10.1056/NEJMp2600529?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

27 263

AI-Based Translation of Discharge Instructions — Aligning Policy with Practice https://www.nejm.org/doi/full/10.1056/NEJMp2603777?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

27 263

The Future of the USPSTF and Evidence-Based Recommendations https://www.nejm.org/doi/full/10.1056/NEJMp2607441?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

27 263

When Fear Became the Barrier to Care — Lessons of a Clinical Rapid Response during Operation Metro Surge https://www.nejm.org/doi/full/10.1056/NEJMp2607981?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

27 263

Infigratinib in Achondroplasia — A Potentially Giant Step Forward https://www.nejm.org/doi/full/10.1056/NEJMe2609749?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 919-920, September 3, 2026.

27 263

Fluid Resuscitation in Patients with Sepsis — For Whom the Balance Tolls https://www.nejm.org/doi/full/10.1056/NEJMe2609856?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 921-922, September 3, 2026.

27 263

Case 20-2026: A 38-Year-Old Man with Abdominal Pain https://www.nejm.org/doi/full/10.1056/NEJMx260023?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 936-936, September 3, 2026.

27 263

Hypomethylating Agents plus Venetoclax as Compared with Intensive Chemotherapy in Patients with AML https://www.nejm.org/doi/full/10.1056/NEJMe2607967?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 917-919, September 3, 2026.

27 263

A Zoonotic Orthonairovirus from Febrile Patients in China https://www.nejm.org/doi/full/10.1056/NEJMc2602496?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 929-931, September 3, 2026.

27 263

Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders https://www.nejm.org/doi/full/10.1056/NEJMc2603114?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 926-929, September 3, 2026.

27 263

Childhood Vaccine Hesitancy https://www.nejm.org/doi/full/10.1056/NEJMc2608837?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 933-934, September 3, 2026.

27 263

More on Causes of Death among Children and Adolescents in the United States https://www.nejm.org/doi/full/10.1056/NEJMc2608518?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 934-936, September 3, 2026.

27 263

Telitacicept for IgA Nephropathy https://www.nejm.org/doi/full/10.1056/NEJMc2608517?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 931-933, September 3, 2026.

27 263

Physical Examination for Asymptomatic Adults https://www.nejm.org/doi/full/10.1056/NEJMclde2515158?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, Page 923-925, September 3, 2026.

27 263

Acro-Osteolysis https://www.nejm.org/doi/full/10.1056/NEJMicm2605116?af=R&rss=currentIssue New England Journal of Medicine, Volume 395, Issue 9, September 3, 2026.

27 263

NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion. http://www.nejm.org/doi/full/10.1056/NEJMp2608826 Elizabeth Tobin-Tyler is a professor of health services, policy and practice at the Brown University School of Public Health and of family medicine and medical science at Warren Alpert Medical School of Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Tobin-Tyler and G. Chalker. Telehealth Access to Mifepristone — Evaluating Reproductive-Coercion Arguments. N Engl J Med 2026;395:833-835.

27 263

NEJM This Week — September 3, 2026 http://www.nejm.org/toc/nejm/395/9 This week, we feature new research on acute myeloid leukemia, achondroplasia, pediatric septic shock, and RAS-mutant lung cancer. We also review the evaluation and management of pulmonary nodules and follow a diagnostic case of recurrent fractures. Perspectives explore reproductive health care, the human–animal bond in health care access, and on creating space for patients’ voices in clinical decision making.

27 263

Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism https://www.nejm.org/doi/full/10.1056/NEJMoa2608012?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.

27 263

Immediate Ambulatory Electrocardiographic Monitoring in Syncope https://www.nejm.org/doi/full/10.1056/NEJMoa2605812?af=R&rss=currentIssue New England Journal of Medicine, Ahead of Print.